Sep 6, 2016 12:00:00 AM

Proteomics Investigates Biomarkers for Early Detection Blood Test for Mesothelioma

Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has begun the detailed search for proteins associated with asbestos-related cancer mesothelioma.

Media Release

2016

PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International Laboratories Ltd (Proteomics...

“Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, has...

NEW YORK – Diagnostics firm Proteomics International (PIL) plans to launch its proteomic test for...

Proteomics Investigates Biomarkers for Early Detection Blood Test for Mesothelioma

Related posts

Business News Asia – PromarkerD Diagnostic Test Leader Officially Launched

Finfeed – Proteomics awarded vital CE Mark registration for PromarkerD

Proteomics International Planning Australia Launch of Endometriosis Test in Q2; US Launch to Follow – 360Dx